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Abstract  25 
Mycoplasma bovis is an emerging bacterial agent causing bovine mastitis. Although these cell wall-26 
free bacteria lack classical virulence factors, they are able to activate the immune system of the 27 
host. However, effects on the bovine mammary immune system are not yet well characterized and 28 
detailed knowledge would improve the prevention and therapy of mycoplasmal mastitis. The aim of 29 
this study was to investigate the immunogenic effects of M. bovis on the mammary gland in an 30 
established primary bovine mammary epithelial cell (bMEC) culture system. Primary bMEC of four 31 
different cows were challenged with live and heat-inactivated M. bovis strain JF4278 isolated from 32 
acute bovine mastitis, as well as with the type strain PG45. The immune response was evaluated 6 33 
and 24 h after mycoplasmal challenge by measuring the relative mRNA expression of selected 34 
immune factors by quantitative PCR. M. bovis triggered an immune response in bMEC, reflected by 35 
the upregulation of tumor necrosis factor-α, interleukin(IL)-1β, IL-6, IL-8, lactoferrin, Toll-like 36 
receptor-2, RANTES, and serum amyloid A mRNA. Interestingly, this cellular reaction was only 37 
observed in response to live, but not to heat-inactivated M. bovis, in contrast to other bacterial 38 
pathogens of mastitis such as Staphylococcus aureus. This study provides evidence that bMEC 39 
exhibit a strong inflammatory reaction in response to live M. bovis. The lack of a cellular response 40 
to heat-inactivated M. bovis supports the current hypothesis that mycoplasmas activate the immune 41 
system through secreted secondary metabolites. 42 
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Introduction  45 
Mycoplasmas represent the smallest self-replicating microorganisms characterized by a minimal 46 
genome, and by the lack of a cell wall (Razin et al., 1998). In dairy cattle, Mycoplasma bovis 47 
belongs to the most prevalent contagious mastitis pathogens (Olde Riekerink et al., 2006) that is 48 
often unresponsive to antibiotics and tends to cause chronic infections (Kauf et al., 2007).  49 
In general, bacterial species and strain specific severities of mastitis are characterized by differences 50 
in their induction of the mammary immune system, i.e. the regulation of several immune factors 51 
(i.e. cytokines) and recognition receptors (i.e. toll-like receptors; TLR) (Wellnitz and Bruckmaier, 52 
2012; Zbinden et al., 2014). M. bovis displays a broad range of immunogenic and 53 
immunosuppressive characteristics that determine its pathogenicity. The extensive variation of cell 54 
surface antigens, also known as variable surface proteins (Vsps), enables the pathogen to evade the 55 
host immunity which contributes to the persistent nature of M. bovis infections (Razin et al., 1998; 56 
Buchenau et al., 2010). Among these Vsps, lipoproteins represent the most abundant fraction (Razin 57 
et al., 1998). Besides their antigenic properties, lipoproteins play a central role in adhesion and are 58 
expected to trigger the production of pro-inflammatory cytokines (Pilo et al., 2007). Furthermore, 59 
Mycoplasma-derived secondary metabolites have been demonstrated to exert cytotoxic effects in 60 
infected host cells (Pilo et al., 2005).
 
61 
As M. bovis resists antibiotic therapies, it is of high importance to understand the bovine 62 
mammary immune response to this pathogen to optimize prevention and therapy strategies of 63 
mycoplasmal mastitis in dairy cows. Therefore, the objective of the present study was to investigate 64 
the innate immune response of bovine mammary epithelial cells (bMEC) to M. bovis, characterized 65 
by the mRNA expression of selected immune factors. Primary cultures of bMEC challenged with 66 
live and heat-inactivated M. bovis were used to investigate host-pathogen interactions that trigger 67 
the immune reaction in the mammary epithelium. 68 
 69 
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Materials and Methods  70 
M. bovis strains 71 
The field strain JF4278, isolated from mastitic milk in 2008 in Switzerland (Aebi et al., 2012), and 72 
the type strain PG45 (Hale et al., 1962) were used in this study. M. bovis cultures were grown in 73 
SP4 broth medium supplemented with 50 μg/ml cefoxitin sodium salt (Sigma-Aldrich, Buchs, 74 
Switzerland) for 18 hours (Freundt, 1983). 75 
To standardize the assays, standard growth curves relating turbidity (OD600) of liquid cultures to 76 
colony forming units (CFU) of M. bovis were obtained by determining colony counts on SP4 agar 77 
supplemented with 50 μg/ml cefoxitin sodium salt incubated for 3-4 days at 37 °C in a humidified 78 
atmosphere. Growth of M. bovis was tested to assess variations among each individual SP4 batch. 79 
Each culture was centrifuged for 30 min at 400 g and at 4 °C. The pellet was suspended in 80 
challenge medium consisting of DMEM/F12 supplemented with 5 % FBS, and ITS containing 0.5 81 
mg/ml insulin, 0.5 mg/ml apo-transferrin, 0.5 µg/ml sodium selenite (all components were received 82 
from Sigma-Aldrich, Buchs, Switzerland) to reach the appropriate concentration. To evaluate the 83 
effective mycoplasmal concentrations, serial 10-fold dilutions of M. bovis cultures were 84 
simultaneously plated on SP4 agar for colony enumeration. For heat-inactivation, M. bovis 85 
suspensions were incubated for 30 min at 95 °C. The efficiency of this method was previously 86 
assessed by plating serial 10-fold dilutions of the M. bovis suspension on SP4 agar plates. 87 
 88 
Treatment of bMEC with live or heat-inactivated M. bovis  89 
Primary cultures of mammary gland epithelial cells of four lactating Holstein dairy cows with 90 
clinically healthy udders (somatic cell count <10
5 
cells/ml) were performed as previously described 91 
(Wellnitz and Kerr, 2004). Mammary tissue was removed directly after slaughter with permission 92 
of the slaughterhouse Marmy SA, Estavayer-le-Lac, Switzerland. Cells were passaged twice and 93 
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cryopreserved in DMEM/F12 containing 20 % FBS and 10 % DMSO (Sigma-Aldrich, Buchs, 94 
Switzerland) and stored in aliquots at –80 °C until the experiment. 95 
Exogenous Mycoplasma sp. contamination of cell cultures from all four cows was excluded 96 
using the Venor™GeM Mycoplasma Detection Kit (Minerva Biolabs, Berlin, Germany) following 97 
the manufacturer's instructions.  98 
Cells from all cows were thawed and separately cultured in growth medium (DMEM/F12 99 
supplemented with 10 % FBS, penicillin G [500 units, Sigma-Aldrich], streptomycin [100 µg/ml, 100 
Sigma-Aldrich], and ITS). After two passages, cells were seeded at a concentration of 3 x 10
5
 101 
cells/well on BD Falcon™ 6-well cell culture plates (BD Biosciences, San Jose, CA, USA). On the 102 
following day, growth medium was replaced with medium without antibiotics. 103 
Assuming that 3 x 10
5
 cells/well after 24 h of incubation and a confluence of about 70 % 104 
represent approximately 1 x 10
6
 cells/well, bMEC were challenged with an expected multiplicity of 105 
infection (MOI) of 150 of live, or heat-inactivated M. bovis suspensions. As a positive control, cells 106 
were challenged with 150 MOI of heat-inactivated S. aureus strain 1904 from bovine mastitis 107 
(Zbinden et al., 2014). Cells incubated in growth medium only served as negative controls.  108 
Cells were grown and incubated at 37 °C with 5 % CO2. 109 
 110 
Total RNA extraction and quantitative real-time PCR 111 
After 6 and 24 h of incubation cells were harvested with 1 ml peqGOLD Trifast™ (PEQLAB 112 
Biotechnologie GmbH, Erlangen, Germany). Total RNA was extracted according to the 113 
manufacturer’s protocol. Reverse transcription with Moloney Murine Leukemia Virus Reverse 114 
Transcriptase (M-MLV RT; Promega Corp., Madison, WI, USA) and quantitative real-time PCR 115 
analysis using the Sensimix DNA Kit (Quantace, Biolabo, Châtel St. Denis, Switzerland) on a 116 
Rotor-Gene 6000 (Corbett Research, Sydney, Australia) was described before (Zbinden et al., 117 
2014). Primer sequences and annealing temperatures are shown in table 1. 118 
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Cycle threshold (Ct) values were determined by the Rotor-Gene software version 1.7.75, and the 119 
relative mRNA expression was calculated using the comparative Ct method using the following 120 
equation (Schmittgen and Livak, 2008): ΔCt = Ct target gene – Ct endogenous control (arithmetic 121 
mean of housekeeping genes). 122 
To visualize the impact of M. bovis, or S. aureus on the immune response of bMEC, data are 123 
presented as ΔΔCt ± SEM, where: ΔΔCt = ΔCt sample (6, or 24 h; treated) – ΔCt negative control 124 
(6, or 24 h; untreated). 125 
 126 
Statistical Analysis 127 
Data from the cells of four cows were expressed as means ± SEM from ∆∆Ct values of the selected 128 
factors. Statistical analysis of the inflammatory response data was tested for significance (P < 0.05) 129 
by ANOVA using PROC MIXED of SAS (Release 9.4; SAS Institute Inc., Cary, NC, USA). The 130 
model included time, strain, and their interaction as fixed effects, and the cow as repeated subject. A 131 
Bonferroni correction was applied. 132 
 133 
Results 134 
Cell cultures 135 
Primary bMEC cultures of all four cows grew to an approximate confluence of 70% within ~20 h 136 
after seeding into 6-well plates. According to Venor™GeM Mycoplasma Detection Kit, the cultures 137 
of all cows were free of Mycoplasma sp. contamination. After 24 h of incubation with live or heat-138 
inactivated mycoplasmas, cells were nearly confluent, and no morphological changes were visible. 139 
 140 
Growth of M. bovis strains 141 
For both M. bovis strains a MOI of 150 was expected based on the assumption/observation that an 142 
OD600 value of 0.1 corresponded to 4.2 x 10
8
 CFU/ml and 1.65 x 10
9
 CFU/ml, for JF4278 and 143 
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PG45, respectively. The plating of serial dilutions indicated that the growth kinetics differed 144 
between M. bovis strains, resulting in effective MOIs of 108 (JF4278), and 30 (PG45), respectively. 145 
Plating of heat-inactivated M. bovis did not result in any bacterial growth. 146 
 147 
Relative mRNA expression of immune factors 148 
The mRNA expression of measured immune factors was not increased in negative controls.  149 
In cells challenged with S. aureus 1904 as positive control, an expected induction of mRNA 150 
expression of interleukin (IL)-1β, tumor-necrosis factor (TNF)-α, IL-8, serum amyloid A (SAA), 151 
lactoferrin (Lf), and TLR2 after 6 h and 24 h of stimulation was detectable. The chemokine 152 
RANTES (regulated on activation, normal T-cell expressed and secreted) was induced at 6 h, but 153 
not at 24 h after challenge. IL-6, IL-10, cyclooxygenase (COX)-2, TLR1, and TLR6 were not 154 
expressed at the mRNA level at either of the time points in response to S. aureus.  155 
Induction of mRNA expression after challenge and differences between challenges with live and 156 
heat-inactivated M. bovis are shown in Table 2 and Figure 1. Transcription of IL-1β, TNF-α, and 157 
IL-8 significantly increased (P<0.05) in bMEC infected with live M. bovis at both, 6 and 24 h post 158 
infection. The abundance of IL-6 mRNA was increased in response to JF4278 after 24 h. RANTES 159 
was only induced at 6 h post infection in bMEC infected by live JF4278 whereas SAA was 160 
upregulated in bMEC at 24 h post infection with both live M. bovis strains. Lactoferrin mRNA 161 
expression was upregulated in bMEC 6 h after infection with live PG45, whereas transcription of Lf 162 
was increased 24 h after infection with both live M. bovis strains. Expression of TLR2 mRNA was 163 
transiently induced after 6 h in response to live JF4278, and at 24 h post infection in response to 164 
live PG45. Interleukin-10, COX-2, TLR1, and TLR6 were not induced in bMEC by either live or 165 
heat-inactivated M. bovis. With heat-inactivated M. bovis, only IL-8 mRNA was upregulated after 6 166 
h of challenge by JF4278. A further increase of mRNA expression from 6 to 24 h of challenge was 167 
only detectable for SAA and Lf with live mycoplasmas. 168 
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 169 
Discussion  170 
Cryopreserved primary bMEC cultures in a low passage were previously shown to 171 
immunologically respond to different bacteria that play a role in mastitis development (Wellnitz and 172 
Kerr, 2004). The cells responded to the stimulation with M. bovis by increased transcription of 173 
genes relevant in mammary gland innate immunity, which confirms the suitability of this model to 174 
investigate the immune response to mycoplasmas. As all cell cultures were free of Mycoplasma sp. 175 
contamination, a cellular response induced by other Mycoplasma species than M. bovis was 176 
excluded. The biological reproducibility was provided by using cells from four different cows. 177 
Different periods of challenge (6 and 24 h) were used to investigate immune factor expression in 178 
earlier and later phases of the response. The S. aureus strain 1904 was used as a positive control 179 
(Zbinden et al., 2014) and proved responsiveness of the cultures used.  180 
M. bovis strain JF4278 used in the present study represents a Swiss field strain that was isolated 181 
from severe mastitis in 2008, when M. bovis mastitis outbreaks started to emerge in Switzerland 182 
(Aebi et al., 2012).
 
In parallel, bMEC were challenged with the type strain PG45 that was isolated in 183 
1961 in the US (Hale et al., 1962). Both M. bovis strains induced an immune response in bMEC in 184 
the present study; however, a direct quantitative comparison is not possible since effective MOIs 185 
were not identical due to differential growth. Although Wellnitz et al. (2006) found that an 186 
increasing MOIs of E. coli or S. aureus did not necessarily result in a stronger immune response in 187 
bMEC, an effect of the bacterial cell concentration used for infection/challenge can be possible. 188 
An experimental mammary M. bovis infection increased the pro-inflammatory cytokines TNF-α 189 
and IL-1β in milk (Kauf et al., 2007). This was reflected by the transcriptional upregulation of IL-190 
1β and TNF-α in bMEC in the present study. The cytokine IL-6 seems to be involved at later stages 191 
of the inflammatory response of bMEC to M. bovis, since live M. bovis JF4278 induced IL-6 192 
transcription not until 24 h after stimulation.  193 
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Chemokines like IL-8 or RANTES mediate the influx of neutrophils from the blood to the site of 194 
infection, reflected by an increase of milk somatic cell count during mastitis. In bMEC IL-8 mRNA 195 
expression was increased by M. bovis which is in agreement with increased milk IL-8 196 
concentrations M. bovis mastitis (Kauf et al., 2007).  197 
Acute phase protein synthesis also reflects an immune response. In this study, SAA expression 198 
significantly raised 24 h after infection with live M. bovis but not with heat inactivated 199 
mycoplasmas. Since SAA is known to act as a chemoattractant, pathogens that upregulate SAA 200 
transcription are likely to be associated with an increase of somatic cell count in the mammary 201 
gland, which could influence the progress of the mastitis (Badolato et al., 1994). 202 
The enzyme COX-2 is involved in prostaglandin synthesis that is upregulated in pulmonary 203 
epithelial cells from pigs by Mycoplasma hyopneumoniae (Andrada et al., 2014). However, in the 204 
present study COX-2 was not upregulated in bMEC in response to either of the M. bovis strains.  205 
Lactoferrin is an antibacterial protein that is produced by mammary epithelial cells during 206 
clinical bovine mastitis (Wellnitz and Bruckmaier, 2012). Live M. bovis induced Lf transcription in 207 
the present study. The earlier induction of Lf transcription of strain PG45 compared to JF4278 208 
despite the lower MOI could indicate that Lf expression follows a strain-dependent mechanism. 209 
Although it was reported that Lf production increases over time in bMEC cultures, likely due to the 210 
increasing cell density (Wellnitz and Kerr, 2004), the increased transcription of Lf was not due to 211 
this effect since control cells did not express increased levels of Lf mRNA during the time of the 212 
experiment.  213 
Toll-like receptors, i.e. TLR2 in combination with TLR1 or TLR6, on the surface of host cells 214 
recognize lipopeptides within the cell membranes of mycoplasmas (Omueti et al., 2005). The slight 215 
increase of TLR2 transcription in bMEC after infection with M. bovis shows that TLR2 is involved 216 
in M. bovis recognition by mammary epithelial cells. In contrast, transcription of TLR1, and TLR6 217 
was not affected.  218 
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Mycoplasmal infections are not necessarily associated with a strong inflammatory response and 219 
can proceed without apparent clinical symptoms (Chambaud et al., 1999). In the present study the 220 
immune suppressive cytokine IL-10 was not upregulated in bMEC by M. bovis, which is consistent 221 
with the results of Lahouassa et al. (2007). An increase of IL-10 in milk after experimental infection 222 
of cows with M. bovis shown by Kauf et al. (2007) could be derived from other immune cells. 223 
Most interestingly, in contrast to other mastitis pathogens like E. coli or S. aureus (Griesbeck-224 
Zilch et al., 2008; Zbinden et al., 2014), bMEC responded only to live, but not to heat-inactivated 225 
M. bovis. For Mycoplasma mycoides subsp. mycoides, it was previously shown that heat-226 
inactivation results in impaired cytotoxicity (Dedieu et al., 2005). The main reason for this 227 
difference is that cell wall containing bacteria have components like lipoteichoic acid, 228 
peptidoglycans, or lipopolysaccharide that are recognized by the host immune system, whereas 229 
wall-less mycoplasmas do not have these classical virulence factors. Therefore, mycoplasmas 230 
exhibit alternative mechanisms that induce an immune response in bMEC, which are apparently 231 
antagonized by heat treatment. Putative M. bovis-specific immunogenic factors include cell surface 232 
molecules such as lipoproteins that are recognized by bMEC via TLRs. However, the most 233 
important role in the activation of an immune response seem to play secreted metabolites that are 234 
associated with cell damage and, as a consequence, inflammation and disease (Pilo et al., 2007).  235 
In conclusion, the present study indicates that an infection with M. bovis induces a considerable 236 
immune response in bMEC shown by increased transcription of several immune factors. 237 
Remarkably, a substantial immune response only occurs if bMEC are infected with live but not with 238 
heat-inactivated M. bovis, indicating a role of released metabolites in the activation of the mammary 239 
immune response.  240 
 241 
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Table 1. Sequences, accession numbers, annealing temperature of the PCR primers, and length of 322 
the PCR products. 323 
Gene
a
 Sequence 5’→3’ 
GenBank 
accession no. 
Annealing 
temperature 
(°C) 
Length 
(bp) 
TNF-α for CCA CGT TGT AGC CGA CAT Cb NM173966 60 155 
 rev CCC TGA AGA GGA CCT GTG AG
b
    
IL-1β for AGT GCC TAC GCA CAT GTC TTCb M37211 60 114 
 rev TGC GTC ACA CAG AAA CTC GTC
b
    
IL-6 for CTT CAC AAG CGC CTT CAC TC
b 
NM173923.2 62 132 
 rev GTC AGA AGT AGT CTG CCT GG
c 
   
IL-8 for ATG ACT TCC AAG CTG GCT GTT G
b
 AF232704 60 149 
 rev TTG ATA AAT TTG GGG TGG AAA G
b
    
RANTES for GCC AAC CCA GAG AAG AAG TG
b
 BC102064 60 119 
 rev CTG CTT AGG ACA AGA GCG AGA
b
    
SAA for GGG CAT CAT TTT CTG CTT CCT
d 
AF540564 60 106 
 rev TTG GTA AGC TCT CCA CAT GTC TTT AG
d 
   
COX-2 for TCC TGA AAC CCA CTC CCA ACA
e
 NM174445 62 242 
 rev TGG GCA GTC ATC AGG CAC AG
e
    
Lf for GGC CTT TGC CTT GGA ATG TAT
e
 L08604 62 338 
 rev ATT TAG CCA CAG CTC CCT GGA G
e
    
TLR1 for ACT TGG AAT TCC TTC TTC ACG A
f 
NM001046504 60 176 
 rev GGA AGA CTG AAC ACA TCA TGG A
f 
   
TLR2 for GGT TTT AAG GCA GAA TCG TTT G
f 
NM174197 60 190 
 rev AAG GCA CTG GGT TAA ACT GTG T
f 
   
TLR6 for CCT TGT TTT TCA CCC AAA TAG C
f 
NM001001159 60 154 
 rev TAA GGT TGG TCC TCC AGT GAG T
f 
   
15 
 
IL-10 for TGT TGA CCC AGT CTC TGC TG
g
 NM174088.1 60 94 
 rev GGC ATC ACC TCT TCC AGG TA
g
    
GAPDH for GTC TTC ACT ACC ATG GAG AAG G
b
 NM001034034 60 197 
 rev TCA TGG ATG ACC TTG GCC AG
b
    
Ubiquitin for AGA TCC AGG ATA AGG AAG GCA T
b
 NM174133 62 198 
 rev GCT CCA CCT CCA GGG TGA T
b
    
for = forward, rev = reverse. 324 
a
RANTES = regulated on activation, normal T cell expressed and secreted; SAA = serum amyloid 325 
A; COX-2 = cyclooxygenase-2; Lf = lactoferrin. 326 
Primer sequence references : 
b
(Griesbeck-Zilch et al., 2008); 
c
(Zarrin et al., 2014), 
d
(Mukesh et al., 327 
2010), 
e
(Zbinden et al., 2014), 
f
(Davies et al., 2008), 
g
(Dreesen et al., 2012). 328 
329 
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Table 2. Changes of mRNA abundance (Mean ± SEM ΔΔCtc) of immune factors in bMEC 330 
challenged with 2 strains of live or heat-inactivated (h.i.) M. bovis for 6 or 24 h. 331 
 332 
  JF4278  PG45 
Gene
d 
Time (h) live h.i.  live h.i. 
TNF-α 6 4.5 ± 0.9 a* 1.8 ± 0.8 b  4.9 ± 0.4 A* 0.4 ± 1.0 B 
 24 4.9 ± 0.4 
a*
 -0.3 ± 1.0 
b 
 4.4 ± 0.5 
A*
 0.5 ± 0.4 
B 
IL-1β 6 7.9 ± 1.0 a* 1.6 ± 1.1 b  7.9 ± 1.1 A* -0.2 ± 0.2 B 
 24 8.1 ± 0.7 
a*
 0.2 ± 0.5 
b
  9.2 ± 0.5 
A*
 -0.1 ± 0.4
 B
 
IL-6 6 0.9 ± 2.2 
a
 0.5 ± 0.3 
a
  1.8 ± 0.6 
A
 0.0 ± 0.6 
A
 
 24 2.1 ± 0.4 
a*
 -0.1 ± 0.1 
a
  2.2 ± 1.0 
A
 -0.2 ± 0.6 
A
 
IL-8 6 5.6 ± 0.9 
a*
 1.1 ± 0.3 
b*
  5.6 ± 0.3 
A*
 0.3 ± 0.3 
B
 
 24 7.1 ± 1.1 
a*
 1.3 ± 1.1 
b
  7.6 ± 1.0 
A*
 0.1 ± 1.3 
B
 
RANTES 6 1.3 ± 0.4 
a*
 1.0 ± 0.8 
a
  0.3 ± 0.4 
A
 -1.2 ± 0.9 
A
 
 24 1.3 ± 0.6 
a
 -0.7 ± 0.9 
a
  1.6 ± 0.8 
A
 -0.5 ± 0.6 
A
 
SAA 6 3.1 ± 1.8 
a
 0.4 ± 1.2 
a
  2.9 ± 1.6 
A
 -0.3 ± 1.8 
A
 
 24 8.5 ± 0.7 
a*#
 -0.6 ± 0.4 
b
  7.7 ± 0.1 
A*#
 -1.1 ± 0.7 
B
 
COX-2 6 0.6 ± 0.8 
a
 0.7 ± 1.2 
a
  1.4 ± 1.0 
A
 0.1 ± 0.9 
A
 
 24 0.5 ± 1.5 
a
 0.1 ± 0.6 
a
  3.0 ± 1.2 
A
 2.2 ± 1.1 
A
 
Lf 6 0.1 ± 0.3 
a
 -0.4 ± 0.3 
a
  1.1 ± 0.2 
A*
 -1.4 ± 0.3 
B
 
 24 4.4 ± 1.0 
a*#
 0.3 ± 0.7 
b
  4.0 ± 1.4 
A*#
 -1.3 ± 0.1 
B
 
TLR1 6 0.6 ± 0.5 
a
 0.0 ± 1.0 
a
  0.7 ± 0.2 
A
 0.3 ± 2.0 
A
 
 24 -1.6 ± 0.7 
a
 -0.4 ± 0.3 
a
  -0.8 ± 0.4 
A
 -0.6 ± 0.8 
A
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TLR2 6 1.9 ± 0.3 
a*
 0.2 ± 0.7 
b
  1.1 ± 1.0 
A
 -0.4 ± 0.8 
A
 
 24 1.2 ± 0.9 
a
 0.4 ± 0.6 
a
  2.3 ± 0.7 
A*
 1.0 ± 0.5 
A
 
TLR6 6 0.1 ± 0.5 
a 
-0.3 ± 0.2 
a
  0.0 ± 0.7 
A
 0.0 ± 0.9 
A
 
 24 -1.3 ± 0.6 
a
 -0.9 ± 0.3 
a
  -0.5 ± 0.5 
A
 0.2 ± 0.4 
A
 
IL-10 6 1.4 ± 1.6 
a
 0.7 ± 1.3 
a
  0.9 ± 1.0 
A
 0.4 ± 0.4 
A
 
 24 -2.8 ± 0.6 
a
 0.0 ± 0.4 
a
  -2.3 ± 0.8 
A
 0.3 ± 0.5 
A
 
*Means differ significantly from negative control. 333 
#
Means between 6 h and 24 h treatment differ significantly. 334 
a, b
Means between live and heat-inactivated JF4278 without common superscript letters differ 335 
(P<0.05). 336 
A,B
Means between live and heat-inactivated PG45 without common superscript letters differ 337 
(P<0.05). 338 
cΔΔCt values are normalized to negative controls and corrected for the two reference genes, 339 
GAPDH and ubiquitin. 340 
d
RANTES = regulated on activation, normal T cell expressed and secreted; SAA = serum amyloid 341 
A; COX-2 = cyclooxygenase-2; Lf = lactoferrin. 342 
 343 
344 
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Figure. 1. Changes of TNF-α relative mRNA abundance as a representative for several other 345 
immune factors in bMEC challenged with M. bovis JF4278. 346 
Changes of relative mRNA abundance (ΔΔCt) of TNF-α in bMEC challenged for 6 h, or 24 h with 347 
live or heat-inactivated (h.i.) M. bovis strain JF4278 (108 MOI). Data are presented as Means ± 348 
SEM.  349 
a,b,A,B
Means within time point between live and heat-inactivated JF4278 without common 350 
superscript letters differ (P<0.05). 351 
*Means differ from negative control (P<0.05). 352 
 353 
 354 
 355 
